Peter R. Meyer

1.1k total citations
13 papers, 906 citations indexed

About

Peter R. Meyer is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Peter R. Meyer has authored 13 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Virology and 6 papers in Molecular Biology. Recurrent topics in Peter R. Meyer's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (5 papers). Peter R. Meyer is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (5 papers). Peter R. Meyer collaborates with scholars based in United States, Sweden and Germany. Peter R. Meyer's co-authors include Walter A. Scott, S. Matsuura, Antero G. So, A. Mohsin Mian, Raymond F. Schinazi, Anthony J. Smith, John W. Mellors, Johan Lennerstrand, Brendan Larder and Adviye Ayper Tolun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Peter R. Meyer

13 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter R. Meyer United States 10 832 777 291 133 51 13 906
Yasuko Sakagami Japan 12 694 0.8× 684 0.9× 285 1.0× 107 0.8× 44 0.9× 17 823
Christel Van den Eynde Belgium 8 640 0.8× 592 0.8× 79 0.3× 126 0.9× 120 2.4× 13 764
Louise Doyon Canada 11 585 0.7× 583 0.8× 143 0.5× 95 0.7× 72 1.4× 14 796
Alyssa R. Martin United States 7 481 0.6× 774 1.0× 211 0.7× 155 1.2× 38 0.7× 14 889
C K Shih United States 6 459 0.6× 454 0.6× 245 0.8× 93 0.7× 24 0.5× 8 645
Galina N. Nikolenko United States 11 530 0.6× 523 0.7× 180 0.6× 89 0.7× 11 0.2× 17 582
Tania Ivens Belgium 9 624 0.8× 473 0.6× 95 0.3× 214 1.6× 220 4.3× 14 772
Mauricio Carobene Argentina 10 393 0.5× 465 0.6× 97 0.3× 97 0.7× 30 0.6× 15 553
Margriet Van Houtte Germany 10 797 1.0× 784 1.0× 111 0.4× 67 0.5× 48 0.9× 20 839
Leila Sarih‐Cottin France 10 235 0.3× 271 0.3× 331 1.1× 50 0.4× 57 1.1× 14 446

Countries citing papers authored by Peter R. Meyer

Since Specialization
Citations

This map shows the geographic impact of Peter R. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Meyer more than expected).

Fields of papers citing papers by Peter R. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Meyer. The network helps show where Peter R. Meyer may publish in the future.

Co-authorship network of co-authors of Peter R. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Meyer. A scholar is included among the top collaborators of Peter R. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Meyer. Peter R. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Rutvisuttinunt, Wiriya, Peter R. Meyer, & Walter A. Scott. (2008). Interactions between HIV-1 Reverse Transcriptase and the Downstream Template Strand in Stable Complexes with Primer-Template. PLoS ONE. 3(10). e3561–e3561. 4 indexed citations
3.
Meyer, Peter R., Wiriya Rutvisuttinunt, S. Matsuura, Antero G. So, & Walter A. Scott. (2007). Stable Complexes Formed by HIV-1 Reverse Transcriptase at Distinct Positions on the Primer-template Controlled by Binding Deoxynucleoside Triphosphates or Foscarnet. Journal of Molecular Biology. 369(1). 41–54. 22 indexed citations
4.
Meyer, Peter R., Anthony J. Smith, S. Matsuura, & Walter A. Scott. (2006). Chain-Terminating Dinucleoside Tetraphosphates Are Substrates for DNA Polymerization by Human Immunodeficiency Virus Type 1 Reverse Transcriptase with Increased Activity against Thymidine Analogue-Resistant Mutants. Antimicrobial Agents and Chemotherapy. 50(11). 3607–3614. 16 indexed citations
5.
Smith, Anthony J., Peter R. Meyer, Deshratn Asthana, M. Ashman, & Walter A. Scott. (2005). Intracellular Substrates for the Primer-Unblocking Reaction by Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Detection and Quantitation in Extracts from Quiescent- and Activated-Lymphocyte Subpopulations. Antimicrobial Agents and Chemotherapy. 49(5). 1761–1769. 26 indexed citations
6.
Meyer, Peter R., Anthony J. Smith, S. Matsuura, & Walter A. Scott. (2004). Effects of Primer-Template Sequence on ATP-dependent Removal of Chain-terminating Nucleotide Analogues by HIV-1 Reverse Transcriptase. Journal of Biological Chemistry. 279(44). 45389–45398. 29 indexed citations
7.
Meyer, Peter R., S. Matsuura, Rahul Chopra, et al.. (2003). Relationship between 3′-Azido-3′-Deoxythymidine Resistance and Primer Unblocking Activity in Foscarnet-Resistant Mutants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Journal of Virology. 77(11). 6127–6137. 56 indexed citations
8.
Meyer, Peter R., Johan Lennerstrand, S. Matsuura, Brendan Larder, & Walter A. Scott. (2003). Effects of Dipeptide Insertions between Codons 69 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Primer Unblocking, Deoxynucleoside Triphosphate Inhibition, and DNA Chain Elongation. Journal of Virology. 77(6). 3871–3877. 54 indexed citations
9.
Meyer, Peter R., S. Matsuura, Adviye Ayper Tolun, et al.. (2002). Effects of Specific Zidovudine Resistance Mutations and Substrate Structure on Nucleotide-Dependent Primer Unblocking by Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 46(5). 1540–1545. 53 indexed citations
10.
Meyer, Peter R., S. Matsuura, Raymond F. Schinazi, Antero G. So, & Walter A. Scott. (2000). Differential Removal of Thymidine Nucleotide Analogues from Blocked DNA Chains by Human Immunodeficiency Virus Reverse Transcriptase in the Presence of Physiological Concentrations of 2′-Deoxynucleoside Triphosphates. Antimicrobial Agents and Chemotherapy. 44(12). 3465–3472. 93 indexed citations
11.
Meyer, Peter R., S. Matsuura, A. Mohsin Mian, Antero G. So, & Walter A. Scott. (1999). A Mechanism of AZT Resistance. Molecular Cell. 4(1). 35–43. 288 indexed citations
12.
Meyer, Peter R., S. Matsuura, Antero G. So, & Walter A. Scott. (1998). Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proceedings of the National Academy of Sciences. 95(23). 13471–13476. 252 indexed citations
13.
Engels, Peter & Peter R. Meyer. (1993). Inactivation of the transcriptional-dependent inhibition of plasmid replication: a selection method for cloning large DNA fragments.. PubMed. 14(3). 324–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026